Adult rats are more sensitive to the vascular effects induced by hyperhomocysteinemia than young rats

Vascular Pharmacology

Volumn 53, Issue 3-4, 2010, Pages 99-106

  de Andrade, Claudia Roberta ^a   de Campos, Glenda Andréa Déstro ^a   Tirapelli, Carlos Renato ^a   Laurindo, Francisco R M ^a   Haddad, Renato ^b   Eberlin, Marcos N ^b   de Oliveira, Ana Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Aging; Hyperhomocysteinemia; Rat carotid artery; Vascular reactivity; Young

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACETYLCHOLINE; CALCIUM; CALCIUM CHLORIDE; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; NITRATE; NITRITE; PHENYLEPHRINE; PROSTAGLANDIN SYNTHASE; RHO KINASE; SUPEROXIDE;

AGE; AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CALCIUM CELL LEVEL; CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; HYPERHOMOCYSTEINEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; AGE FACTORS; AMIDES; ANIMALS; CALCIUM CHLORIDE; CAROTID ARTERIES; CYCLOOXYGENASE INHIBITORS; ENDOTHELIUM, VASCULAR; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; INDOMETHACIN; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PHENYLEPHRINE; PYRIDINES; RATS; RATS, WISTAR; RHO-ASSOCIATED KINASES; SUPEROXIDES; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 77956190437     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2010.04.006     Document Type: Article

References (54)

1. Alexander R.W. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995, 25:155-161.
2. Bonaventura D., Tirapelli C.R., Haddad R., Höehr N.F., Eberlin M.N., de Oliveira A.M. Chronic methionine load-induced hyperhomocysteinemia enhances rat carotid responsiveness for angiotensin II. Pharmacology 2004, 70(2):91-99.
3. Bonaventura D., Tirapelli C.R., de Oliveira A.M. Chronic methionine load-induced hyperhomocysteinemia impairs the relaxation induced by bradykinin in the isolated rat carotid. Amino Acids 2009, 37(4):617-627.
4. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049-1057.
5. Brandes R.P., Fleming I., Busse R. Endothelial aging. Cardiovasc. Res. 2005, 6:286-294.
6. Büssemaker E., Pistrosch F., Förster S., Herbrig K., Gross P., Passauer J., Brandes R.P. Rho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H541-H547.
7. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., Georgakopoulos D., Robinson J., Deanfield J.E. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J. Am. Coll. Cardiol. 1994, 24:471-476.
8. Chen C., Conklin B.S., Ren Z., Zhong D.S. Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries. J. Surg. Res. 2002, 102(1):22-30.
9. Chitaley K., Webb R.C. Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling. Hypertension 2002, 39:438-442.
10. Choudhury L., Marsh J.D. Myocardial infarction in young patients. Am. J. Med. 1999, 107:254-261.
11. Csiszar A., Ungvari Z., Edwards J.G., Kaminski P., Wolin M.S., Koller A., Kaley G. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. 2002, 90:1159-1166.
12. de Andrade C.R., Fukada S.Y., Olivon V.C., de Godoy M.A., Haddad R., Eberlin M.N., Cunha F.Q., de Souza H.P., Laurindo F.R., de Oliveira A.M. Alpha1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia. Eur. J. Pharmacol. 2006, 543:83-91.
13. de Andrade C.R., Leite P.F., Montezano A.C., Casolari D.A., Yogi A., Tostes R.C., Haddad R., Eberlin M.N., Laurindo F.R., de Souza H.P., Corrêa F.M., de Oliveira A.M. Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia. Br. J. Pharmacol. 2009, 157(4):568-580.
14. de Andrade C.R., Tirapelli C.R., Haddad R., Eberlin M.N., Ramalho L.N., Iyomasa M.M., Uyemura S.A., de Oliveira A.M. Hyperhomocysteinemia induced by feeding rats diets rich in dl-homocysteine thiolactone promotes alterations on carotid reactivity independent of arterial structure. Vasc. Pharmacol. 2009, 51(4):291-298.
15. Delp M.D., Behnke B.J., Spier S.A., Wu G., Muller-Delp J.M. Ageing diminishes endothelium-dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles. J. Physiol. 2008, 586:1161-1168.
16. Eskurza I., Kahn Z.D., Seals D.R. Xanthine oxidase does not contribute to impaired peripheral conduit artery endothelium-dependent dilatation with ageing. J. Physiol. 2006, 571:661-668.
17. Hamsten A., Eféndic S., Walldius G., Szamosi A., de Faire U. Glucose tolerance and insulin response to glucose in nondiabetic young male survivors of myocardial infarction. Am. Heart J. 1987, 113(4):917-927.
18. Harker L.A., Ross R., Slichter S.J., Scott C.R. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 1976, 58(3):731-741.
19. Harrison G. Cellular and molecular mechanisms of endothelial dysfunction. J. Clin. Invest. 1997, 100:2153-2157.
20. 2+ channels in rat aortic smooth muscle. Br. J. Anaesth. 1998, 81:578-583.
21. Hirsch S., Ronco A.M., Vasquez M., de la Maza M.P., Garrido A., Barrera G., Gattas V., Glasinovic A., Leiva L., Bunout D. Hyperhomocysteinemia in healthy young men and elderly men with normal serum folate concentration is not associated with poor vascular reactivity or oxidative stress. J. Nutr. 2004, 134(7):1832-1835.
22. Horowitz A., Menice C.B., Laporte R., Morgan K.G. Mechanisms of smooth muscle contraction. Physiol. Rev. 1996, 76:967-1003.
23. 2+ removal upon vascular smooth muscle contraction induced by noripenephrine, histamine and potassium. J. Pharm. Exp. Ther. 1968, 159:91-97.
24. Huemer M., Vonblon K., Födinger M., Krumpholz R., Hubmann M., Ulmer H., Simma B. Total homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and body mass index in healthy children and adolescents. Pediatr. Res. 2006, 60(6):764-769.
25. Jin L., Ying Z., Webb R.C. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1495-H1500.
26. (2+)](i) oscillations underlying tonic contraction in the rabbit inferior vena cava. J. Physiol. 2001, 534:641-650.
27. Lentz S.R., Sobey C.G., Piegors D.J., Bhopatkar M.Y., Faraci F.M., Malinow M.R., Heistad D.D. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J. Clin. Invest. 1996, 98(1):24-29.
28. Luscher T.F., Tanner F.C., Tschundi M.R., Noll G. Endothelial dysfunction in coronary artery disease. Annu. Rev. Med. 1993, 44:395-418.
29. McEniery C.M., Wilkinson I.B., Avolio A.P. Age, hypertension and arterial function. Clin. Exp. Pharmacol. Physiol. 2007, 34(7):665-671.
30. Muller-Delp J.M., Spier S.A., Ramsey M.W., Delp M.D. Aging impairs endothelium-dependent vasodilation in rat skeletal muscle arterioles. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1662-H1672.
31. Nakakuki T., Ito M., Iwasaki H., Kureishi Y., Okamoto R., Moriki N., Kongo M., Kato S., Yamada N., Isaka N., Nakano T. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2088-2093.
32. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 1997, 337:230-236.
33. Okatani Y., Wakatsuki A., Reiter R.J. Melatonin counteracts potentiation by homocysteine of KCL-induced vasoconstriction in human umbilical artery: relation to calcium influx. Biochem. Biophys. Res. Commun. 2001, 280:940-944.
34. Perry D.J. Hyperhomocysteinemia. Best Pract. Res. Clin. Haematol. 1999, 12:451-477.
35. Powers A.K., Majors S.L., Cerula H.A., Huber B.P. Changes in markers of vascular injury in response to transient hyperhomocysteinemia. Metabolism 2003, 52:501-507.
36. Rodgers G.M., Conn M.T. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 1990, 75:895-901.
37. Rubanyi G.M. The role of endothelium in cardiovascular homeostasis and diseases. J. Cardiovasc. Pharmacol. 1993, 22(Suppl 4):S1-S14.
38. Seals D.R., Moreau K.L., Gates P.E., Eskurza I. Modulatory influences on ageing of the vasculature in healthy humans. Exp. Gerontol. 2006, 41:501-507.
39. Sellke F.W., Boyle E.M., Verrier E.D. Endothelial cell injury in cardiovascular surgery: the pathophysiology of vasomotor dysfunction. Ann. Thorac. Surg. 1996, 62:1222-1228.
40. Sindler A.L., Delp M.D., Reyes R., Wu G., Muller-Delp J.M. Effects of ageing and exercise training on eNOS uncoupling in skeletal muscle resistance arterioles. J. Physiol. 2009, 587(Pt 15):3885-3897.
41. Stamler J.S., Osborne J.A., Jaraki O., Rabbani L.E., Mullins M., Singel D., Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 1993, 91:308-318.
42. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed endothelia cell injury from homocysteine. J. Clin. Invest. 1986, 77:1370-1376.
43. Stuhlinger M.C., Tsao P.S., Her J.H., Kimoto M., Balint R.F., Cooke J.P. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001, 104:2569-2575.
44. Taddei S., Virdis A., Ghiadoni L., Salvetti G., Bernini G., Magagna A., Salvetti A. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 2001, 38:274-279.
45. Thompson G.R., Maher V.M., Matthews S., Kitano Y., Neuwirth C., Shortt M.B., Davies G., Rees A., Mir A., Prescott R.J. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet 1995, 345(8953):811-816.
46. Tirapelli C.R., De Andrade C.R., Lieberman M., Laurindo F.R., De Souza H.P., de Oliveira A.M. Vitamin K1 (phylloquinone) induces vascular endothelial dysfunction: role of oxidative stress. Toxicol. Appl. Pharmacol. 2006, 213(1):10-17.
47. Ueland P.M., Refsum H.M. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J. Lab. Clin. Chem. 1989, 114:473-501.
48. Ungvari Z., Pacher P., Rischak K., Szollar L., Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1899-1904.
49. Verhaar M.C., Stroes E., Rabelink T.J. Folates and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2002, 22(1):6-13.
50. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr. Drug Metab. 2005, 6:27-36.
51. Welch G.N., Upchurch G.R., Loscalzo J. Homocysteine, oxidative stress, and vascular disease. Hosp. Pract. 1997, 32:81-92.
52. Welch G.N., Upchurch G.R., Farivar R.S., Pigazzi A., Vu K., Brecher P., Keaney J.F., Loscalzo J. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2. Proc. Assoc. Am. Physicians 1998, 110(1):22-31.
53. Woodman C.R., Price E.M., Laughlin M.H. Selected contribution: aging impairs nitric oxide and prostacyclin mediation of endothelium-dependent dilation in soleus feed arteries. J. Appl. Physiol. 2003, 95:2164-2170.
54. Zimmerman F.H., Cameron A., Fisher L.D., Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J. Am. Coll. Cardiol. 1995, 26:654-661.